References
- Honrubia V, Bell TS, Harris MR, Baloh RW, Fisher LM. Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol 1996; 17: 595 602.
- Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990; 116:424–7.
- Dziadziola JK, Laurikainen EL, Rachel JD, Quirk WS. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg 1999; 120: 400–5.
- Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985; 111: 73–84.
- Botta L, Mira E, Valli S, Perin P, Zucca G, Valli P. Effects of betahistine on vestibular receptors of the frog. Acta Otolaryngol (Stockh) 1998; 118: 519–23.
- Botta L, Mira E, Valli S, et al. Effects of betahistine metabolites on frog ampullar receptors. Acta Otolar�yngol 2000; 120: 25–7.
- Frew IJC, Menon GN. Betahistine hydrochloride in Meniere's disease. Postgrad Med J 1976; 52: 501 3.
- Wilmot TJ, Menon GN. Betahistine in Meniere's disease. J Laryngol Otol 1976; 90: 833 40.
- Claes J, Van de Heyning PH. A review of medical treatment for Meniere's disease. Acta Otolaryngol Suppl 2000; 544: 34 9.
- Oosterveld WJ. Betahistine dihydrochloride in the treat�ment of vertigo of peripheral vestibular origin. A double-blind placebo controlled study. J Laryngol Otol 1984; 98: 37–41.
- Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Flunarizine. A review of its pharmacodynamic and phamacokinetic properties and therapeutic use. Drugs 1984; 27: 6–44.
- Haid T. Evaluation of flunarizine in patients with Meniere's disease. Subjective and vestibular findings. Acta Otolaryngol (Stockh) 1988; 460: 149–53.
- Elbaz P. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a dou�ble-blind study. Acta Otolaryngol (Stockh) 1988; 460: 143–8.
- Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R. Betahistine dihydrochloride versus flunarizine. A dou-ble-blind study on recurrent vertigo with or without cochlear syndrome typical of Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1991; 490: 1 10.
- Gioffr� P. I questionari anamnestici. In: Guidetti G, ed. Diagnosi e terapia dei disturbi dell, equilibrio'. Rome: Editore Marrapese, 1996: 191–203.
- Committee on Hearing, and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995; 113: 181–5.
- Laurikainen EL, Miller JF, Pyykko I. Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl 2000; 544: 5–7.
- Valli P. Betahistine reduces the resting firing rate of vestibular receptors in the frog. Acta Otolaryngol Suppl 2000; 544: 8 10.
- Costantinescu L, Schneider D, Claussen CF. The influence of betahistine on the vestibular evoked poten�tials in patients with peripheral vestibular disorders. 3rd European Congress EUFOS, Budapest, Hungary, 9–14 June, 1996: 95.
- Kingma H, Bonink M, Meulenbroeks A, Konijnenberg H. Dose-dependent effect of betahistine on the vestib-ular-ocular reflex: a double-blind, placebo controlled study in patients with paroxysmal vertigo. Acta Otolar�yngol (Stockh) 1997; 117: 641–6.
- Perez N, Espinosa JM, Fernandez S, Garcia-Tapia R. Use of distortion-product otoacoustic emissions for auditory evaluation in Meniere's disease. Eur Arch Otorhinolaryngol 1997; 254: 329–42.
- Tighilet B, Lacour M. Histamine immunoreactivity changes in vestibular-lesioned and histaminergic-treated cats. Eur J Pharmacol 1997; 330: 65–77.
- Lacour M, Tighilet B. Vestibular compensation in the cat: the role of the histaminergic system. Acta Otolar�yngol Suppl 2000; 544: 15–8.
- Dutia MB. Betahistine, vestibular function and com�pensation: in vitro studies of vestibular function and plasticity. Acta Otolaryngol Suppl 2000; 544: 11 4.
- Colletti V Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating post�operative compensation. Acta Otolaryngol Suppl 2000; 544: 27–33.